Expression of β‐catenin in basal cell carcinoma

Summary Background β‐Catenin is a crucial member of the E‐cadherin/catenin complex, which plays a major role in cell–cell adhesion. β‐Catenin is also known to be involved in signal transduction pathways. Many studies have demonstrated changes in the expression of β‐catenin in colorectal carcinomas, suggesting a role for β‐catenin in neoplastic development.

[1]  A. Chu,et al.  Abnormal immunoreactivity of the E‐cadherin/catenin (α‐, β‐, and γ‐) complex in premalignant and malignant non‐melanocytic skin tumours , 2002 .

[2]  R. Poulsom,et al.  The expression of E-cadherin and catenins in sporadic colorectal carcinoma. , 2001, Human pathology.

[3]  Hui Zheng,et al.  Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Sato,et al.  β‐Catenin gene mutation in human hair follicle‐related tumors , 2001, Pathology international.

[5]  T. Kwast,et al.  Expression of E-cadherin, α- & β-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma , 1999 .

[6]  J. Jankowski,et al.  Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. , 1999, Molecular pathology : MP.

[7]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[8]  K. Syrigos,et al.  E‐cadherin/catenin complex in benign and malignant melanocytic lesions , 1998, The Journal of pathology.

[9]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[10]  Rippey.  Why classify basal cell carcinomas? , 1998, Histopathology.

[11]  J. Rippey,et al.  Incompletely excised basal cell carcinomas of the skin , 1997, The Medical journal of Australia.

[12]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[13]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[14]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[15]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[16]  H. L. Parlette,et al.  Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. , 1996, Archives of dermatology.

[17]  Y. Niitsu,et al.  Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39 , 1995, Molecular and cellular biology.

[18]  S. Walton,et al.  The emerging epidemic of skin cancer , 1994, The British journal of dermatology.

[19]  P. McCrea,et al.  Catenins as mediators of the cytoplasmic functions of cadherins , 1993, Journal of Cell Science.

[20]  S. Hirohashi,et al.  Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization , 1992, Cell.

[21]  F. Mohs,et al.  Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. , 1991, Journal of the American Academy of Dermatology.

[22]  D. Jones,et al.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.

[23]  M. Ringwald,et al.  Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Lang,et al.  Histologic evolution of recurrent basal cell carcinoma and treatment implications. , 1986, Journal of the American Academy of Dermatology.

[25]  G. Jacobs,et al.  Prediction of aggressive behavior in basal cell carcinoma , 1982, Cancer.

[26]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[27]  J. Sloane.  The value of typing basal cell carcinomas in predicting recurrence after surgical excision , 1977, The British journal of dermatology.

[28]  山崎 文恵.  Immunohistochemical detection for nuclear β-catenin in sporadic basal cell carcinoma , 2002 .

[29]  A. Chu,et al.  Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. , 2002, The Journal of pathology.

[30]  G. Moreno-Bueno,et al.  beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles. , 2001, The British journal of dermatology.

[31]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[32]  E. Fuchs,et al.  A common human skin tumour is caused by activating mutations in beta-catenin. , 1999, Nature genetics.

[33]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.